[144] Blend Labs, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 Notice of Proposed Sale filed by Blend Labs (NYSE: BLND) on June 28, 2025, detailing insider trading activity. The filing indicates a proposed sale of 20,000 shares of common stock with an aggregate market value of $63,315 through Charles Schwab & Co.

Key transaction details:

• Securities were originally acquired on February 17, 2020, through an Exercise and Hold transaction
• Sale represents a small portion of total outstanding shares (254,775,978 shares)
• Planned execution date: June 23, 2025
• Previous insider activity: The seller (Brian Kneafsey) sold 45,000 shares on June 16, 2025, for gross proceeds of $145,268

The seller affirms no knowledge of undisclosed material adverse information regarding Blend Labs' operations. This Form 144 represents a declaration of intent to sell securities acquired through stock options, indicating potential insider sentiment.

Positive

• None.

Negative

• Insider Brian Kneafsey has sold a total of 65,000 shares in the past month (45,000 shares on 6/16/2025 for $145,268 and plans to sell additional 20,000 shares worth $63,315), indicating potential lack of confidence from company insiders

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	20000	63315.00	254775978	06/23/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2020	Exercise and Hold	BLEND LABS, INC.			20000	02/17/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian Kneafsey 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 94945	Blend Labs, Inc.	06/16/2025	45000	145268.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many BLND shares are being sold by insiders according to the June 2025 Form 144?

According to the Form 144 filing dated June 28, 2025, an insider plans to sell 20,000 shares of BLND common stock through Charles Schwab & Co., Inc. with an aggregate market value of $63,315.00.

Who is selling BLND shares in the June 2025 Form 144 filing and what is their recent trading history?

Brian Kneafsey is the seller, and according to the filing, he previously sold 45,000 shares of BLND on June 16, 2025, for gross proceeds of $145,268.00. The new proposed sale is for an additional 20,000 shares.

What is the total number of BLND shares outstanding as of June 2025?

According to the Form 144 filing, Blend Labs, Inc. (BLND) has 254,775,978 shares outstanding as of June 2025.

How did the selling BLND insider acquire their shares?

The insider acquired the 20,000 shares on February 17, 2020, through an 'Exercise and Hold' transaction from Blend Labs, Inc. The shares were paid for in cash at the time of acquisition.

What is the planned date of sale for the BLND shares in the Form 144?

The approximate date of sale listed in the Form 144 filing is June 23, 2025, and the shares will be sold on the NYSE (New York Stock Exchange).